Dr. Lynn M. Schuchter is the Chief of the Hematology/Oncology Division in the Department of Medicine at the University of Pennsylvania Perelman School of Medicine. Her research is focused on the development of new treatments for patients with melanoma in studies that have focused on immunotherapy and targeted approaches. Dr. Schuchter has a strong passion for mentorship and has trained many physicians and scientists interested in oncology research. In addition to her research, she is a busy clinician with a focus on patients with melanoma and has been practicing for over 20 years.
Dr. Lynn Mara Schuchter was very attentive, a great listener, I could see her actively listening and thinking before she responded. Her manner is a quiet confidence which made me very comfortable and able to listen to her diagnosis and her recommendations. I would recommend her to anyone who needs treatment for melanoma.
Dr. Schuchter is amazing. She has lead me through my melanoma journey for the last 16 years. She has been my rock. She is an expert in her area as well as a kind, caring and warm individual. When I am with her, I have all of her attention and I know that she genuinely cares about me. She will even call me after our visit if she feels the need. She has touched my life in such a positive way. I am beyond thankful for her.
Dr. Lynn Schuchter is a very special individual. She renewed my hope for getting through this challenging time. I feel so fortunate to have her on my team!
Recognized by America’s Top Doctors, 2007, 2008, 2010 - 2018
Recognized by Best Doctors in America, 2003 - 2018
Recognized by Main Line Today’s Top Doctor’s 2016 issue
Recognized annually in Philadelphia magazine’s Top Docs issues from 2004 to 2018
Internal Medicine, 1985
Medical Oncology, 1989
Novel clinical trials
Surveillance and diagnosis
Medical School: Chicago Medical School
Residency: Michael Reese Hospital
Medical Oncology Fellowship: Johns Hopkins Hospital
Aetna US Healthcare
Amerihealth Caritas Medicare
Clover Health Plan
Devon Health Services (Americare)
Gateway Health Plan
Geisinger Health Plan
HealthAmerica / HealthAssurance, a Coventry Plan
Highmark Blue Shield
Horizon Blue Cross Blue Shield of New Jersey
Humana / Choicecare
Independence Blue Cross (Keystone East)
Keystone First Medicare
Oxford Health Plan
PA Health and Wellness (Centene) Medicare
Preferred Health Care/LGH
Rail Road Medicare / Palmetto GBA
Remedy Partners at Penn Medicine
UnitedHealthcare Community Plan
US Family Health Plan
Veterans Choice Program
Our Melanoma Program at the Abramson Cancer Center’s Melanoma Program has set a standard in excellence for developing and testing new melanoma prevention strategies, conducting history-making, life-saving clinical trials, and translating new findings from the laboratory to the clinical setting. Our mission is to provide outstanding and compassionate care to patients and their families during their entire cancer journey.
I am continually inspired by my patients. Their courage, their grace, and their determination. My patients will always be my motivation – patients who are in need of better options to fight their melanoma and patients who demonstrate a bravery that is so inspiring. My mission is to cure melanoma!
Tara Miller was an incredibly energetic, persuasive, amazing young woman who died at age 28 from melanoma. She taught us every day what it is to make the best of it, what it is to invest in research, what it is to raise awareness. Her legacy is that her friends, family, and community embody her message and continue to deliver it. She wanted to invest in research not just to buy time for people, but to give a lifetime to people. She created the Tara Miller Foundation to raise funds to cure melanoma. We miss Tara every day, but her bravery will be Tara’s legacy at the Abramson Cancer Center and Penn.
Keywords: Melanoma, Skin Cancer